Hormone Erythropoietin for Treating Multiple Myeloma

 

Prof. Emeritus Nechama Haran-Ghera, in collaboration with Israeli physicians, showed that the hormone erythropoietin may be helpful in treating multiple myeloma and other cancers. In mice injected with myeloma cells, the hormone prolonged survival, caused tumor regression and reduced mortality.

 

 

Haran-Ghera’s research provided the scientific basis for clinical trials of erythropoietin in multiple myeloma and for testing the effects of this hormone on other types of cancer.